Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas

Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing, Xiang, Wei, Yi, Dong-ye, Xue, Bing-zhou, Wen, Wan-wan, Abdelmaksoud, Ahmed, Xiong, Nan-xiang, Jiang, Xiao-bing, Zhao, Hong-yang, Fu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109313/
https://www.ncbi.nlm.nih.gov/pubmed/30143053
http://dx.doi.org/10.1186/s13287-018-0977-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109313/
https://www.ncbi.nlm.nih.gov/pubmed/30143053
http://dx.doi.org/10.1186/s13287-018-0977-z

Ejemplares similares